Retrovirus-induced oncogenesis and safety of retroviral vectors.
about
Novel therapeutic approaches for various cancer types using a modified sleeping beauty-based gene delivery systemDevelopment of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature developmentAdvances in ultrasound mediated gene therapy using microbubble contrast agents.A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in miceTargeting HIV-1 DNA integration by swapping tethersSerial bone marrow transplantation reveals in vivo expression of the pCLPG retroviral vector.Repetitive busulfan administration after hematopoietic stem cell gene therapy associated with a dominant HDAC7 clone in a nonhuman primate.High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapyStem cells in clinical practice: applications and warnings.Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer modelsDevelopment and characterization of an enhanced nonviral expression vector for electroporation cancer treatment.Genetic control of wayward pluripotent stem cells and their progeny after transplantation.Antiangiogenic and Neurogenic Activities of Sleeping Beauty-Mediated PEDF-Transfected RPE Cells In Vitro and In VivoEngineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectorsBarriers for Deriving Transgene-Free Pig iPS Cells with Episomal VectorsSupplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells.RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.Use of stem cells for liver diseases-current scenario.Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon.Removal of reprogramming transgenes improves the tissue reconstitution potential of keratinocytes generated from human induced pluripotent stem cells.Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposonA Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression.Para amino benzoic acid-derived self-assembled biocompatible nanoparticles for efficient delivery of siRNA.
P2860
Q28660424-77C88D4D-53D3-491C-A407-F6A50161A2A3Q30434991-249B6505-592C-4BA4-8517-640455CE888FQ30458491-C78E9CD2-638B-40BD-B72B-9AF806E7B56EQ30493690-324E3DC5-2280-4F59-8245-E7FB2A2A9C16Q33733706-3AA53DFD-5AF9-452E-ACF0-CE51AA21DE47Q33753483-E5B1AACB-2FD4-4668-B780-91359717A2C5Q34123262-66FF4E5E-36E8-4F10-ADB9-DEE6DA3F6F96Q34329364-5425E9E7-8234-4177-83A6-E961243EF110Q34552765-1706A881-5AE1-46A9-A580-13C2F6DE3479Q34904172-BBBE5421-61D0-4101-B0E3-774D4937DA3CQ35184157-38F6DD49-42BE-4D80-81D7-BABD9E03730EQ35661899-C05F2F7F-390E-4CC8-B6DA-09F236096DFEQ36369034-C802B8CA-13E7-4019-BE12-3F5B00D38CA2Q37075772-C9CE0EA1-2720-4754-B501-62DF1B76B50FQ37259489-F28F59F4-ED37-4E7B-8FF0-063B26E89555Q37618532-4056E575-3738-4780-A3DA-722C90BAE419Q38121503-1B328ED3-DEED-4604-B035-26D3A1759C8DQ38371445-B8557A2B-FEE7-47F1-853B-321D5E6108E0Q39863924-C43F058C-29BB-491E-AD4A-ADE5681EAE4AQ40291779-9761FC68-0B7E-4195-BB9C-39305D73CEBDQ41811170-67F052FD-78B0-46EC-9C9A-38C8253CE9B4Q41815168-8960B87E-87C6-4F6E-9582-A9C55A0AF8EEQ42118383-67806754-C6AA-4411-A4B1-174E22903AF2Q43216544-E27930FF-3994-40A1-A570-D0C664BFED9A
P2860
Retrovirus-induced oncogenesis and safety of retroviral vectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retrovirus-induced oncogenesis and safety of retroviral vectors.
@en
Retrovirus-induced oncogenesis and safety of retroviral vectors.
@nl
type
label
Retrovirus-induced oncogenesis and safety of retroviral vectors.
@en
Retrovirus-induced oncogenesis and safety of retroviral vectors.
@nl
prefLabel
Retrovirus-induced oncogenesis and safety of retroviral vectors.
@en
Retrovirus-induced oncogenesis and safety of retroviral vectors.
@nl
P1476
Retrovirus-induced oncogenesis and safety of retroviral vectors
@en
P2093
Venugopal Nair
P304
P577
2008-10-01T00:00:00Z